Cargando…
The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections
Multi-drug resistant (MDR) Gram-negative bacteria represent a growing threat, with an increasing prevalence of carbapenem-resistant Enterobacterales (CRE) infections, for which treatment options are limited. New treatment combinations composed of a β-lactam antibiotic plus a potent β-lactamase inhib...
Autor principal: | Bouza, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632744/ https://www.ncbi.nlm.nih.gov/pubmed/34849998 http://dx.doi.org/10.1093/jac/dkab353 |
Ejemplares similares
-
Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections
por: Bassetti, Matteo, et al.
Publicado: (2021) -
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
por: Doi, Yohei
Publicado: (2019) -
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
por: Nordmann, Patrice, et al.
Publicado: (2019) -
Education: An overview from the author of ‘Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-negative infections in intensive care unit patients’
por: Falcone, Marco
Publicado: (2021) -
Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram
por: Chen, Chen, et al.
Publicado: (2023)